Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Rockwell Medical (RMTI) Debt to Equity (2018 - 2025)

Rockwell Medical (RMTI) has disclosed Debt to Equity for 10 consecutive years, with $0.28 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Debt to Equity fell 22.55% year-over-year to $0.28, compared with a TTM value of $0.28 through Sep 2025, down 22.55%, and an annual FY2024 reading of $0.33, down 34.36% over the prior year.
  • Debt to Equity was $0.28 for Q3 2025 at Rockwell Medical, roughly flat from $0.28 in the prior quarter.
  • Across five years, Debt to Equity topped out at $8.11 in Q4 2021 and bottomed at -$3.83 in Q1 2022.
  • Average Debt to Equity over 5 years is $0.78, with a median of $0.52 recorded in 2024.
  • The sharpest move saw Debt to Equity skyrocketed 1215.13% in 2021, then crashed 572.62% in 2022.
  • Year by year, Debt to Equity stood at $8.11 in 2021, then tumbled by 93.4% to $0.54 in 2022, then fell by 5.35% to $0.51 in 2023, then plummeted by 34.36% to $0.33 in 2024, then dropped by 14.87% to $0.28 in 2025.
  • Business Quant data shows Debt to Equity for RMTI at $0.28 in Q3 2025, $0.28 in Q2 2025, and $0.35 in Q1 2025.